Skip to main content
Clinical Trials/NCT00157144
NCT00157144
Completed
Not Applicable

Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005

Bayside Health1 site in 1 countryOctober 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Distress Syndrome, Adult
Sponsor
Bayside Health
Locations
1
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Extracorporeal membrane oxygenation (ECMO) is a means of artificially performing the function of the human lung and/or heart outside the body. Its use is escalating in a wide range of clinical settings in the adult population without evidence or guidelines to support this practice.

This study involves a nationwide questionnaire which has two components. The initial pilot survey will attempt to identify all institutions currently practicing ECMO or those intending to do so in the future, and are willing to participate in prospective data collection. The second phase will involve a monthly survey of these centres regarding the extent of ECMO use, practice details implemented, and outcome data.

It is hoped that the collection of this information will later assist in the development of guidelines for this expensive and presently unsubstantiated practice, together with the construction of appropriate training programs for staff.

Registry
clinicaltrials.gov
Start Date
October 2004
End Date
August 2006
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Bayside Health
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients receiving ECMO in Australia and New Zealand

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials